5. Cholesterol Pharmacology Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is the relationship between total cholesterol and CHD mortality?

A
  • high levels of cholesterol in blood serum are associated with a high risk of CHD mortality
  • it is however a modifiable risk factor - a 10% reduction in total cholesterol leads to a 15% reduction in CHD mortality
  • LDL cholesterol is the primary target to prevent CHD
  • there is an association between hypertension, smoking and hypercholesterolaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does LDL cholesterol lead to atherosclerosis?

A

1) infiltration of LDL cholesterol into the artery wall
2) entrapment of LDL cholesterol
3) modification of LDL cholesterol
4) uptake of modified cholesterol by macrophages
5) formation of foam cells
6) formation of fatty streaks
7) conversion of fatty streaks to fibrous plaques.

As BMI increases your LDL cholesterol can also increase and HDL cholesterol can decrease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Atherosclerosis is a chronic inflammatory disorder. Explain why Ox-LDL has pro-atherogenic effects?

A
  • reduce macrophage motility
  • induce T cell activation
  • toxic to endothelial cells
  • enhance platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name the 7 types of lipid lowering drugs

PORN CSF

A

most commonly prescribed is statins.

P: plant sterols
O: omega 3 fatty acids
R: resins
N: nicotinic acid/niacin 
C: cholesterol lipase inhibitors
F:fibrates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the mechanism of action of statins.

A
  • inhibit cholesterol synthesis in hepatocytes
  • blocks the enzyme HMG-coA reductase
  • also increase the number of LDL receptors on hepatocytes increasing their uptake and removal from blood
  • minor effects include anti inflammatory, plaque reduction and reduced thrombotic risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the difference between primary and secondary prevention of CVD?

A

Primary: reducing risk mortality in someone who has never had a CVD event but they have other risk factors e.g. diabetes, BP etc.

Secondary: reducing risk mortality in someone who has CVD and has had a CBD event.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name some adverse effects of statins.

A
  • myopathy: diffuse muscle pain and raised CPK
  • hepatocyte toxicity: raised AST levels so LFTs done routinely
  • miscellaneous: GI complaints, arthralgia and headaches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Who should be prescribed statins?

A
  • patients who have a 20% risk of developing CVD in the next 10 year
  • use a risk calculator
  • those who have familial hypercholesterolaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the mechanism of action of fibrates.

A
  • increase production of lipoprotein lipase (PPAR agonists)
  • increase uptake of chylomicrons and VLDLS
  • breaks down triglycerides
  • so slightly reduces LDLS and increases HDL cholesterol in patients with hyper triglyceridaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name some side effects of fibrates

A
  • GI symptoms
  • gall stones (cholelithiasis)
  • inflammation of the muscles (myositis)
  • abnormal LFTs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Who do you not give fibrates to?

A

Those with hepatic or gallbladder disease.

Give as an adjunct to diet modification or with statins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of action of nicotinic acid?

A
  • inhibits lipoprotein synthesis
  • reduces VLDL synthesis
  • increases HDL synthesis more than the other lipid lowering drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the side effects of nicotinic acid drugs

A
  • flushing: warmth, redness and itching
  • hepatocyte toxicity
  • headaches
  • reduced insulin sensitivity, hyperglycaemia
  • GI symptoms - activation of peptic ulcer

Must give aspirin alongside this drug to reduce side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which groups would we not prescribe nicotinic acid to?

A
  • diabetics
  • those with peptic ulcers
  • anyone with abnormal LFTs or liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the mechanism of action of the cholesterol lipase inhibitor ezetimide

A
  • inhibits cholesterol absorption in the small intestine and decreases delivery of cholesterol to the liver
  • increase number of LDL receptors on hepatocytes so they take up more cholesterol, removing it from the blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name the side effects of ezetimide

A
  • GI symptoms: abdominal pain and diarrhoea

- headache

17
Q

Why would we prescribe ezetimide?

A

When a patient cannot tolerate statins

18
Q

What side effects may we see when giving a combination of statins and fibrates?

A
  • statins and fibrates together reduce LDL cholesterol and increased HDL
  • but fibrates reduce the metabolism of statins giving higher plasma concentrations
  • this can lead to increased risk of myopathy and Rhabdomyolysis
19
Q

What is evolocumab?

A
  • it is a monoclonal antibody which inhibits an enzyme (PCSK9)
  • this enzyme normally causes endocytosis of LDL receptors
  • so inhibiting it increases the number of LDL receptors on hepatocytes so they take up more cholesterol removing it for the blood
20
Q

Name some positive and negative dietary modifications with regards to cholesterol

A

Positive:

  • fish oils
  • vitamin C and E
  • fibre

Negative:

  • fatty diet
  • alcohol
21
Q

What is the guidance for prescribing statins in primary prevention?

A
  • offer 20mg atorvastatin
  • for primary prevention of CVD
  • in patients with a 10% or greater 10 year risk of developing CVD
  • use the QRISK2 assessment tool
22
Q

What is the guidance regarding statin treatment in people with CVD?

A
  • start on atorvastatin 80mg

- use a lower dose if there is high risk of ADR, patient preference

23
Q

What reduction in non-HDL cholesterol do we aim for?

A

40%

If not achieved need to discuss adherence, timing of dose, diet and lifestyle measure and possibly increasing dose if started on less than 80mg